Event Calendar
Prev MonthPrev Month Next MonthNext Month
Accept, Connect, Embody: A Psychedelic Therapy Framework
Monday, June 22, 2020, 8:00 AM to Friday, June 26, 2020, 5:00 PM EDT
Category: CE Events: Adult Individuals

Do you hear the call for innovation in mental healthcare? Rising rates of trauma, depression, and addiction, highlight the insufficiency of widely accepted treatment approaches, such as psychopharmacology and short-term talk therapy, in providing lasting relief and transformation. An exciting new treatment paradigm, Psychedelic Therapy, is garnering the support of patients and clinicians across the globe. Psychedelics, such as psilocybin, ayahuasca, and MDMA, are showing promising results in clinical trials and the treatment of seemingly intractable conditions of mind and body. Upcoming studies at Imperial College London and other psychedelic research sites worldwide are exploring psilocybin treatment for depression, anorexia, chronic pain, and other indications. Rather than numbing suffering temporarily, psychedelic therapy has a mechanism akin to an antibiotic rather than an anesthetic, targeting some of the unconscious root causes of a person’s distress. While patients describe Psilocybin treatment sessions as ‘ten years of therapy in one day’ and often experience insights about themselves or ‘seeing things in a new way,’ sessions can be challenging, and thorough therapeutic support is essential. Neuroscientifc findings from psychedelic research suggest that psilocybin induces a highly flexible brain state, disrupting rigid belief patterns, and making space for new ways of thinking and feeling. The weeks and months after a session can provide a ‘window of opportunity’ for forming new habits of mind, body, and community. Patients often report feeling more connected to themselves, others, and nature; increased acceptance of difficult feelings; presence and motivation to pursue valued directions in life. This course will explore the current research indicating psychedelic therapy as a promising direction in medicine. Participants will be introduced to the evidence-based therapy model, Accept, Connect, and Embody (ACE), used in the Imperial College London Psilocybin for Depression Study. The development and applications of the ACE treatment model will be discussed within the greater context of the neuroscientific findings, mechanisms, and core features of psychedelic therapy. Patient screening, preparation, treatment, and integration sessions will be examined. Throughout the workshop, videotapes and experiential exercises will be utilized to demonstrate skills from the psychedelic therapy toolkit. This course is well suited for clinicians of all levels and any provider interested in exploring these groundbreaking findings and innovative approaches to treatment.

Hosted by Cape Cod Institute, Cape Cod Learning Network, LLC in Eastham, MA for 15 CEs. For more info, visit: www.cape.org/register.